{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,8,3]],"date-time":"2026-08-03T14:59:07Z","timestamp":1785769147574,"version":"3.56.0"},"reference-count":74,"publisher":"Springer Science and Business Media LLC","issue":"8","license":[{"start":{"date-parts":[[2026,1,26]],"date-time":"2026-01-26T00:00:00Z","timestamp":1769385600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"},{"start":{"date-parts":[[2026,1,26]],"date-time":"2026-01-26T00:00:00Z","timestamp":1769385600000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"}],"funder":[{"DOI":"10.13039\/100000002","name":"U.S. Department of Health & Human Services | National Institutes of Health","doi-asserted-by":"publisher","award":["CA267971"],"award-info":[{"award-number":["CA267971"]}],"id":[{"id":"10.13039\/100000002","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100000002","name":"U.S. Department of Health & Human Services | National Institutes of Health","doi-asserted-by":"publisher","award":["CA238515"],"award-info":[{"award-number":["CA238515"]}],"id":[{"id":"10.13039\/100000002","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100000002","name":"U.S. Department of Health & Human Services | National Institutes of Health","doi-asserted-by":"publisher","award":["CA238515"],"award-info":[{"award-number":["CA238515"]}],"id":[{"id":"10.13039\/100000002","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Cell Death Differ"],"published-print":{"date-parts":[[2026,8]]},"abstract":"<jats:title>\n                    <jats:bold>Abstract<\/jats:bold>\n                  <\/jats:title>\n                  <jats:p>Mutations in tumor suppressor p53 that gain oncogenic functions (Onc-p53) are frequent in lungs and many other solid tumors often associated with chromosome aberrations. Why cells or tumors with Onc-p53 develop chromosomal aberrations and whether the abnormalities contribute to tumor growth remain elusive. Evidence in this communication demonstrate for the first time that replication stress induced by Onc-p53 triggers re-copying of DNA replication forks, which generates replication intermediates that cause persistent mitotic aberration and DNA segregation errors. Replication intermediates from re-copied replication forks induced by Onc-p53 activate ATM signaling, which stabilizes Onc-p53, reinforces its ability to upregulate replication factors for sustaining replication stress, thus generating a feedforward cycle accelerating tumor formation. In agreement with this observation our time lapse video microscopy show in real time that persistent mitotic aberration and DNA segregation errors induced by Onc-p53 confer selective growth advantage. Accordingly, human lung tumors with Onc-p53 show selection of cells with mitotic aberration during serial passages. Knock down of active replication forks reduces re-copied fork generation by Onc-p53 and specifically induces apoptotic death of lung cancer cells expressing Onc-p53 in xenograft lung tumors in cooperation with inhibitors of ATM activation, deselecting cells with Onc-p53 with mitotic errors. This communication reveals a novel mechanism which interconnects replication stress induced by Onc-p53 to its stabilization and ability to generate chromosomal aberration in lung cancer cells that both accelerate tumor growth and serve as a targetable therapeutic vulnerability. These findings will be extremely valuable for tumor-specific treatment of a high percentage of cancer patients with p53 mutation.<\/jats:p>","DOI":"10.1038\/s41418-026-01670-4","type":"journal-article","created":{"date-parts":[[2026,1,26]],"date-time":"2026-01-26T11:02:28Z","timestamp":1769425348000},"page":"1585-1597","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":0,"title":["Oncogenic p53 induces mitotic errors in lung cancer cells by recopying DNA replication forks conferring targetable proliferation advantage"],"prefix":"10.1038","volume":"33","author":[{"given":"Shilpa","family":"Singh","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-0713-1789","authenticated-orcid":false,"given":"Lilia","family":"Gheghiani","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Brandon","family":"Velasco","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Rebecca","family":"Frum","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Steven R.","family":"Grossman","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Brad","family":"Windle","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sumitra","family":"Deb","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0009-0001-4642-6424","authenticated-orcid":false,"given":"Swati Palit","family":"Deb","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2026,1,26]]},"reference":[{"key":"1670_CR1","unstructured":"p53 MUTATIONS IN LUNG CANCER - p53 WEB SITE. p53freefr\/Database\/p53_cancer\/p53_Lunghtml."},{"key":"1670_CR2","doi-asserted-by":"publisher","first-page":"1239","DOI":"10.1038\/cdd.2015.53","volume":"22","author":"T Soussi","year":"2015","unstructured":"Soussi T, Wiman KG. TP53: an oncogene in disguise. Cell Death Differ. 2015;22:1239\u201349.","journal-title":"Cell Death Differ"},{"key":"1670_CR3","doi-asserted-by":"publisher","first-page":"S21","DOI":"10.1016\/S0305-7372(10)70016-5","volume":"36","author":"G Bronte","year":"2010","unstructured":"Bronte G, Rizzo S, La Paglia L, Adamo V, Siragusa S, Ficorella C, et al. Driver mutations and differential sensitivity to targeted therapies: a new approach to the treatment of lung adenocarcinoma. Cancer Treatt Rev. 2010;36:S21\u20139.","journal-title":"Cancer Treatt Rev"},{"key":"1670_CR4","doi-asserted-by":"publisher","first-page":"375","DOI":"10.1101\/gr.120477.111","volume":"22","author":"F Vandin","year":"2012","unstructured":"Vandin F, Upfal E, Raphael BJ. De novo discovery of mutated driver pathways in cancer. Genome Res. 2012;22:375\u201385.","journal-title":"Genome Res"},{"key":"1670_CR5","doi-asserted-by":"publisher","first-page":"898","DOI":"10.1038\/cdd.2013.17","volume":"20","author":"W Hanel","year":"2013","unstructured":"Hanel W, Marchenko N, Xu S, Yu SX, Weng W, Moll U. Two hot spot mutant p53 mouse models display differential gain of function in tumorigenesis. Cell Death Differ. 2013;20:898\u2013909.","journal-title":"Cell Death Differ"},{"key":"1670_CR6","doi-asserted-by":"publisher","first-page":"847","DOI":"10.1016\/j.cell.2004.11.004","volume":"119","author":"KP Olive","year":"2004","unstructured":"Olive KP, Tuveson DA, Ruhe ZC, Yin B, Willis NA, Bronson RT, et al. Mutant p53 gain of function in two mouse models of Li-Fraumeni syndrome. Cell. 2004;119:847\u201360.","journal-title":"Cell"},{"key":"1670_CR7","doi-asserted-by":"publisher","first-page":"6896","DOI":"10.1038\/sj.onc.1210493","volume":"26","author":"S Zheng","year":"2007","unstructured":"Zheng S, El-Naggar AK, Kim ES, Kurie JM, Lozano G. A genetic mouse model for metastatic lung cancer with gender differences in survival. Oncogene. 2007;26:6896\u2013904.","journal-title":"Oncogene"},{"key":"1670_CR8","doi-asserted-by":"publisher","first-page":"a001107","DOI":"10.1101\/cshperspect.a001107","volume":"2","author":"M Oren","year":"2010","unstructured":"Oren M, Rotter V. Mutant p53 gain-of-function in cancer. Cold Spring Harb Perspect Biol. 2010;2:a001107.","journal-title":"Cold Spring Harb Perspect Biol"},{"key":"1670_CR9","doi-asserted-by":"publisher","first-page":"6","DOI":"10.1016\/j.bbrc.2012.09.029","volume":"428","author":"CA Vaughan","year":"2012","unstructured":"Vaughan CA, Frum R, Pearsall I, Singh S, Windle B, Yeudall A, et al. Allele specific gain-of-function activity of p53 mutants in lung cancer cells. Biochem Biophys Res Commun. 2012;428:6\u201310.","journal-title":"Biochem Biophys Res Commun"},{"key":"1670_CR10","doi-asserted-by":"publisher","first-page":"12426","DOI":"10.18632\/oncotarget.6998","volume":"7","author":"CA Vaughan","year":"2016","unstructured":"Vaughan CA, Pearsall I, Singh S, Windle B, Deb SP, Grossman SR, et al. Addiction of lung cancer cells to GOF p53 is promoted by up-regulation of epidermal growth factor receptor through multiple contacts with p53 transactivation domain and promoter. Oncotarget. 2016;7:12426\u201346.","journal-title":"Oncotarget"},{"key":"1670_CR11","doi-asserted-by":"publisher","first-page":"79","DOI":"10.1016\/j.abb.2011.12.006","volume":"518","author":"CA Vaughan","year":"2011","unstructured":"Vaughan CA, Singh S, Windle B, Sankala HM, Graves PR, Andrew Yeudall W, et al. p53 mutants induce transcription of NF-kappaB2 in H1299 cells through CBP and STAT binding on the NF-kappaB2 promoter and gain of function activity. Arch Biochem Biophys. 2011;518:79\u201388.","journal-title":"Arch Biochem Biophys"},{"key":"1670_CR12","doi-asserted-by":"publisher","first-page":"352","DOI":"10.1038\/nature14430","volume":"523","author":"EM Alexandrova","year":"2015","unstructured":"Alexandrova EM, Yallowitz AR, Li D, Xu S, Schulz R, Proia DA, et al. Improving survival by exploiting tumour dependence on stabilized mutant p53 for treatment. Nature. 2015;523:352\u201356.","journal-title":"Nature"},{"key":"1670_CR13","doi-asserted-by":"publisher","first-page":"298","DOI":"10.1016\/j.ccell.2018.07.004","volume":"34","author":"R Schulz-Heddergott","year":"2018","unstructured":"Schulz-Heddergott R, Stark N, Edmunds SJ, Li J, Conradi LC, Bohnenberger H, et al. Therapeutic ablation of gain-of-function mutant p53 in colorectal cancer inhibits Stat3-mediated tumor growth and invasion. Cancer Cell. 2018;34:298\u2013314.","journal-title":"Cancer Cell"},{"key":"1670_CR14","doi-asserted-by":"publisher","first-page":"1839","DOI":"10.1172\/JCI87724","volume":"127","author":"S Singh","year":"2017","unstructured":"Singh S, Vaughan CA, Frum RA, Grossman SR, Deb S, Palit Deb S. Mutant p53 establishes targetable tumor dependency by promoting unscheduled replication. J Clin Invest. 2017;127:1839\u201355.","journal-title":"J Clin Invest"},{"key":"1670_CR15","doi-asserted-by":"publisher","first-page":"1268","DOI":"10.1101\/gad.190678.112","volume":"26","author":"WA Freed-Pastor","year":"2012","unstructured":"Freed-Pastor WA, Prives C. Mutant p53: one name, many proteins. Genes Dev. 2012;26:1268\u201386.","journal-title":"Genes Dev"},{"key":"1670_CR16","doi-asserted-by":"publisher","first-page":"696","DOI":"10.1002\/1878-0261.12068","volume":"11","author":"CA Vaughan","year":"2017","unstructured":"Vaughan CA, Singh S, Grossman SR, Windle B, Deb SP, Deb S. Gain-of-function p53 activates multiple signaling pathways to induce oncogenicity in lung cancer cells. Mol Oncol. 2017;11:696\u2013711.","journal-title":"Mol Oncol"},{"key":"1670_CR17","doi-asserted-by":"publisher","first-page":"206","DOI":"10.1038\/nature15251","volume":"525","author":"J Zhu","year":"2015","unstructured":"Zhu J, Sammons MA, Donahue G, Dou Z, Vedadi M, Getlik M, et al. Gain-of-function p53 mutants co-opt chromatin pathways to drive cancer growth. Nature. 2015;525:206\u201311.","journal-title":"Nature"},{"key":"1670_CR18","doi-asserted-by":"publisher","DOI":"10.1038\/s41467-021-20928-8","volume":"12","author":"CA Vaughan","year":"2021","unstructured":"Vaughan CA, Singh S, Subler MA, Windle JJ, Inoue K, Fry EA, et al. The oncogenicity of tumor-derived mutant p53 is enhanced by the recruitment of PLK3. Nat Commun. 2021;12:704.","journal-title":"Nat Commun"},{"key":"1670_CR19","doi-asserted-by":"publisher","first-page":"2537","DOI":"10.1101\/gad.226373.113","volume":"27","author":"KJ Neelsen","year":"2013","unstructured":"Neelsen KJ, Zanini IM, Mijic S, Herrador R, Zellweger R, Ray Chaudhuri A, et al. Deregulated origin licensing leads to chromosomal breaks by rereplication of a gapped DNA template. Genes Dev. 2013;27:2537\u201342.","journal-title":"Genes Dev"},{"key":"1670_CR20","doi-asserted-by":"publisher","first-page":"7773","DOI":"10.1038\/sj.onc.1210881","volume":"26","author":"J Bartek","year":"2007","unstructured":"Bartek J, Bartkova J, Lukas J. DNA damage signalling guards against activated oncogenes and tumour progression. Oncogene. 2007;26:7773\u20139.","journal-title":"Oncogene"},{"key":"1670_CR21","doi-asserted-by":"publisher","first-page":"613","DOI":"10.1080\/15384101.2017.1288322","volume":"16","author":"M Fragkos","year":"2017","unstructured":"Fragkos M, Naim V. Rescue from replication stress during mitosis. Cell Cycle. 2017;16:613\u201333.","journal-title":"Cell Cycle"},{"key":"1670_CR22","doi-asserted-by":"publisher","first-page":"9","DOI":"10.1016\/j.dnarep.2016.11.002","volume":"49","author":"HJ Hsieh","year":"2017","unstructured":"Hsieh HJ, Peng G. Cellular responses to replication stress: Implications in cancer biology and therapy. DNA Repair (Amst). 2017;49:9\u201320.","journal-title":"DNA Repair (Amst)"},{"key":"1670_CR23","doi-asserted-by":"publisher","first-page":"2759","DOI":"10.3390\/ijms18122759","volume":"18","author":"V Schmidt","year":"2017","unstructured":"Schmidt V, Nagar R, Martinez LA. Control of Nucleotide Metabolism Enables Mutant p53\u2019s Oncogenic Gain-of-Function Activity. Int J Mol Sci. 2017;18:2759.","journal-title":"Int J Mol Sci"},{"key":"1670_CR24","doi-asserted-by":"publisher","first-page":"189","DOI":"10.1146\/annurev-cellbio-101011-155807","volume":"28","author":"JJ Siegel","year":"2012","unstructured":"Siegel JJ, Amon A. New insights into the troubles of aneuploidy. Annu Rev Cell Dev Biol. 2012;28:189\u2013214.","journal-title":"Annu Rev Cell Dev Biol"},{"key":"1670_CR25","doi-asserted-by":"publisher","first-page":"18","DOI":"10.1007\/s10577-023-09727-7","volume":"31","author":"D Cimini","year":"2023","unstructured":"Cimini D. Twenty years of merotelic kinetochore attachments: a historical perspective. Chromosome Res. 2023;31:18.","journal-title":"Chromosome Res"},{"key":"1670_CR26","doi-asserted-by":"publisher","first-page":"1043","DOI":"10.1038\/nature04217","volume":"437","author":"T Fujiwara","year":"2005","unstructured":"Fujiwara T, Bandi M, Nitta M, Ivanova EV, Bronson RT, Pellman D. Cytokinesis failure generating tetraploids promotes tumorigenesis in p53-null cells. Nature. 2005;437:1043\u20137.","journal-title":"Nature"},{"key":"1670_CR27","doi-asserted-by":"publisher","first-page":"32","DOI":"10.1038\/s41568-018-0084-6","volume":"19","author":"SMA Lens","year":"2019","unstructured":"Lens SMA, Medema RH. Cytokinesis defects and cancer. Nat Rev Cancer. 2019;19:32\u201345.","journal-title":"Nat Rev Cancer"},{"key":"1670_CR28","doi-asserted-by":"publisher","first-page":"149","DOI":"10.1016\/j.dnarep.2015.04.026","volume":"32","author":"D Cortez","year":"2015","unstructured":"Cortez D. Preventing replication fork collapse to maintain genome integrity. DNA repair (Amst). 2015;32:149\u201357.","journal-title":"DNA repair (Amst)"},{"key":"1670_CR29","doi-asserted-by":"publisher","first-page":"a012955","DOI":"10.1101\/cshperspect.a012955","volume":"4","author":"D McIntosh","year":"2012","unstructured":"McIntosh D, Blow JJ. Dormant origins, the licensing checkpoint, and the response to replicative stresses. Cold Spring Harb Perspect Biol. 2012;4:a012955.","journal-title":"Cold Spring Harb Perspect Biol"},{"key":"1670_CR30","doi-asserted-by":"publisher","first-page":"147","DOI":"10.1007\/978-1-62703-236-0_12","volume":"962","author":"RA Frum","year":"2013","unstructured":"Frum RA, Deb S, Deb SP. Use of the DNA fiber spreading technique to detect the effects of mutant p53 on DNA replication. Methods Mol Biol. 2013;962:147\u201355.","journal-title":"Methods Mol Biol"},{"key":"1670_CR31","doi-asserted-by":"publisher","first-page":"926","DOI":"10.1093\/nar\/gkt944","volume":"42","author":"RA Frum","year":"2014","unstructured":"Frum RA, Singh S, Vaughan C, Mukhopadhyay ND, Grossman SR, Windle B, et al. The human oncoprotein MDM2 induces replication stress eliciting early intra-S-phase checkpoint response and inhibition of DNA replication origin firing. Nucleic Acids Res. 2014;42:926\u201340.","journal-title":"Nucleic Acids Res"},{"key":"1670_CR32","doi-asserted-by":"publisher","first-page":"1201","DOI":"10.1016\/j.cell.2017.05.041","volume":"169","author":"JE Graham","year":"2017","unstructured":"Graham JE, Marians KJ, Kowalczykowski SC. Independent and Stochastic Action of DNA Polymerases in the Replisome. Cell. 2017;169:1201\u201313.","journal-title":"Cell"},{"key":"1670_CR33","doi-asserted-by":"publisher","first-page":"60","DOI":"10.1093\/nar\/gkn912","volume":"37","author":"ES Dorn","year":"2009","unstructured":"Dorn ES, Chastain PD 2nd, Hall JR, Cook JG. Analysis of re-replication from deregulated origin licensing by DNA fiber spreading. Nucleic Acids Res. 2009;37:60\u20139.","journal-title":"Nucleic Acids Res"},{"key":"1670_CR34","doi-asserted-by":"publisher","first-page":"699","DOI":"10.1083\/jcb.201212058","volume":"200","author":"KJ Neelsen","year":"2013","unstructured":"Neelsen KJ, Zanini IM, Herrador R, Lopes M. Oncogenes induce genotoxic stress by mitotic processing of unusual replication intermediates. J Cell Biol. 2013;200:699\u2013708.","journal-title":"J Cell Biol"},{"key":"1670_CR35","doi-asserted-by":"publisher","first-page":"243","DOI":"10.1038\/ncb2201","volume":"13","author":"C Lukas","year":"2011","unstructured":"Lukas C, Savic V, Bekker-Jensen S, Doil C, Neumann B, Pedersen RS, et al. 53BP1 nuclear bodies form around DNA lesions generated by mitotic transmission of chromosomes under replication stress. Nat Cell Biol. 2011;13:243\u201353.","journal-title":"Nat Cell Biol"},{"key":"1670_CR36","doi-asserted-by":"publisher","first-page":"1819","DOI":"10.1016\/j.celrep.2017.05.016","volume":"19","author":"S Pellegrino","year":"2017","unstructured":"Pellegrino S, Michelena J, Teloni F, Imhof R, Altmeyer M. Replication-Coupled Dilution of H4K20me2 Guides 53BP1 to Pre-replicative Chromatin. Cell Rep. 2017;19:1819\u201331.","journal-title":"Cell Rep"},{"key":"1670_CR37","doi-asserted-by":"publisher","first-page":"872","DOI":"10.1016\/j.molcel.2013.01.001","volume":"49","author":"C Escribano-Diaz","year":"2013","unstructured":"Escribano-Diaz C, Orthwein A, Fradet-Turcotte A, Xing M, Young JT, Tkac J, et al. A cell cycle-dependent regulatory circuit composed of 53BP1-RIF1 and BRCA1-CtIP controls DNA repair pathway choice. Mol Cell. 2013;49:872\u201383.","journal-title":"Mol Cell"},{"key":"1670_CR38","doi-asserted-by":"publisher","first-page":"2611","DOI":"10.3390\/ijms18122611","volume":"18","author":"A Fernandez-Vidal","year":"2017","unstructured":"Fernandez-Vidal A, Vignard J, Mirey G. Around and beyond 53BP1 Nuclear Bodies. Int J Mol Sci. 2017;18:2611.","journal-title":"Int J Mol Sci"},{"key":"1670_CR39","doi-asserted-by":"publisher","first-page":"8","DOI":"10.1016\/j.dnarep.2015.09.002","volume":"36","author":"CJ Bakkenist","year":"2015","unstructured":"Bakkenist CJ, Kastan MB. Chromatin perturbations during the DNA damage response in higher eukaryotes. DNA repair (Amst). 2015;36:8\u201312.","journal-title":"DNA repair (Amst)"},{"key":"1670_CR40","doi-asserted-by":"publisher","first-page":"877","DOI":"10.1038\/35103059","volume":"2","author":"J Bartek","year":"2001","unstructured":"Bartek J, Falck J, Lukas J. CHK2 kinase-a busy messenger. Nat Rev Mol Cell Biol. 2001;2:877\u201386.","journal-title":"Nat Rev Mol Cell Biol"},{"key":"1670_CR41","doi-asserted-by":"publisher","first-page":"26","DOI":"10.1016\/j.molcel.2022.12.004","volume":"83","author":"N Ratnayeke","year":"2023","unstructured":"Ratnayeke N, Baris Y, Chung M, Yeeles JTP, Meyer T. CDT1 inhibits CMG helicase in early S phase to separate origin licensing from DNA synthesis. Mol Cell. 2023;83:26\u201342.","journal-title":"Mol Cell"},{"key":"1670_CR42","doi-asserted-by":"publisher","first-page":"593","DOI":"10.1038\/ncb2489","volume":"14","author":"D Varma","year":"2012","unstructured":"Varma D, Chandrasekaran S, Sundin LJ, Reidy KT, Wan X, Chasse DA, et al. Recruitment of the human Cdt1 replication licensing protein by the loop domain of Hec1 is required for stable kinetochore-microtubule attachment. Nat Cell Biol. 2012;14:593\u2013603.","journal-title":"Nat Cell Biol"},{"key":"1670_CR43","doi-asserted-by":"publisher","first-page":"752","DOI":"10.1016\/j.tibs.2019.03.011","volume":"44","author":"M Petropoulos","year":"2019","unstructured":"Petropoulos M, Champeris Tsaniras S, Taraviras S, Lygerou Z. Replication Licensing Aberrations, Replication Stress, and Genomic Instability. Trends Biochem Sci. 2019;44:752\u201364.","journal-title":"Trends Biochem Sci"},{"key":"1670_CR44","doi-asserted-by":"publisher","first-page":"31","DOI":"10.1007\/s10577-023-09741-9","volume":"31","author":"JF Marques","year":"2023","unstructured":"Marques JF, Kops G. Permission to pass: on the role of p53 as a gatekeeper for aneuploidy. Chromosome Res. 2023;31:31.","journal-title":"Chromosome Res"},{"key":"1670_CR45","doi-asserted-by":"publisher","first-page":"11547","DOI":"10.1073\/pnas.1934852100","volume":"100","author":"M Overholtzer","year":"2003","unstructured":"Overholtzer M, Rao PH, Favis R, Lu XY, Elowitz MB, Barany F, et al. The presence of p53 mutations in human osteosarcomas correlates with high levels of genomic instability. Proc Natl Acad Sci USA. 2003;100:11547\u201352.","journal-title":"Proc Natl Acad Sci USA"},{"key":"1670_CR46","doi-asserted-by":"publisher","first-page":"7079","DOI":"10.1093\/nar\/gkq571","volume":"38","author":"R Baronio","year":"2010","unstructured":"Baronio R, Danziger SA, Hall LV, Salmon K, Hatfield GW, Lathrop RH, et al. All-codon scanning identifies p53 cancer rescue mutations. Nucleic Acids Res. 2010;38:7079\u201388.","journal-title":"Nucleic Acids Res"},{"key":"1670_CR47","doi-asserted-by":"publisher","first-page":"67","DOI":"10.1093\/carcin\/bgz087","volume":"41","author":"JA Barta","year":"2020","unstructured":"Barta JA, Pauley K, Kossenkov AV, McMahon SB. The lung-enriched p53 mutants V157F and R158L\/P regulate a gain of function transcriptome in lung cancer. Carcinogenesis. 2020;41:67\u201377.","journal-title":"Carcinogenesis"},{"key":"1670_CR48","doi-asserted-by":"publisher","first-page":"284","DOI":"10.3389\/fonc.2015.00284","volume":"5","author":"R Vijayakumaran","year":"2015","unstructured":"Vijayakumaran R, Tan KH, Miranda PJ, Haupt S, Haupt Y. Regulation of mutant p53 protein expression. Front Oncol. 2015;5:284.","journal-title":"Front Oncol"},{"key":"1670_CR49","doi-asserted-by":"publisher","first-page":"293","DOI":"10.1093\/jmcb\/mjy072","volume":"11","author":"X Zhou","year":"2019","unstructured":"Zhou X, Hao Q, Lu H. Mutant p53 in cancer therapy-the barrier or the path. J Mol Cell Biol. 2019;11:293\u2013305.","journal-title":"J Mol Cell Biol"},{"key":"1670_CR50","first-page":"1699","volume":"6","author":"J Bartek","year":"1991","unstructured":"Bartek J, Bartkova J, Vojtesek B, Staskova Z, Lukas J, Rejthar A, et al. Aberrant expression of the p53 oncoprotein is a common feature of a wide spectrum of human malignancies. Oncogene. 1991;6:1699\u2013703.","journal-title":"Oncogene"},{"key":"1670_CR51","first-page":"137","volume":"5","author":"E Reihsaus","year":"1990","unstructured":"Reihsaus E, Kohler M, Kraiss S, Oren M, Montenarh M. Regulation of the level of the oncoprotein p53 in non-transformed and transformed cells. Oncogene. 1990;5:137\u201345.","journal-title":"Oncogene"},{"key":"1670_CR52","doi-asserted-by":"publisher","first-page":"2894","DOI":"10.1158\/1535-7163.MCT-09-0519","volume":"8","author":"SE Golding","year":"2009","unstructured":"Golding SE, Rosenberg E, Valerie N, Hussaini I, Frigerio M, Cockcroft XF, et al. Improved ATM kinase inhibitor KU-60019 radiosensitizes glioma cells, compromises insulin, AKT and ERK prosurvival signaling, and inhibits migration and invasion. Mol Cancer Ther. 2009;8:2894\u2013902.","journal-title":"Mol Cancer Ther"},{"key":"1670_CR53","doi-asserted-by":"publisher","first-page":"1474","DOI":"10.1126\/science.146.3650.1474","volume":"146","author":"HL Ennis","year":"1964","unstructured":"Ennis HL, Lubin M. Cycloheximide: aspects of inhibition of protein synthesis in mammalian cells. Science. 1964;146:1474\u20136.","journal-title":"Science"},{"key":"1670_CR54","doi-asserted-by":"publisher","first-page":"557","DOI":"10.1038\/35087613","volume":"412","author":"M Lopes","year":"2001","unstructured":"Lopes M, Cotta-Ramusino C, Pellicioli A, Liberi G, Plevani P, Muzi-Falconi M, et al. The DNA replication checkpoint response stabilizes stalled replication forks. Nature. 2001;412:557\u201361.","journal-title":"Nature"},{"key":"1670_CR55","doi-asserted-by":"publisher","first-page":"591","DOI":"10.1158\/1535-7163.MCT-10-0928","volume":"10","author":"TJ Guzi","year":"2011","unstructured":"Guzi TJ, Paruch K, Dwyer MP, Labroli M, Shanahan F, Davis N, et al. Targeting the replication checkpoint using SCH 900776, a potent and functionally selective CHK1 inhibitor identified via high content screening. Mol Cancer Ther. 2011;10:591\u2013602.","journal-title":"Mol Cancer Ther"},{"key":"1670_CR56","doi-asserted-by":"publisher","first-page":"2217","DOI":"10.1091\/mbc.E14-11-1563","volume":"26","author":"DR Mackay","year":"2015","unstructured":"Mackay DR, Ullman KS. ATR and a Chk1-Aurora B pathway coordinate postmitotic genome surveillance with cytokinetic abscission. Mol Biol Cell. 2015;26:2217\u201326.","journal-title":"Mol Biol Cell"},{"key":"1670_CR57","doi-asserted-by":"publisher","first-page":"440","DOI":"10.1158\/0008-5472.CAN-09-1947","volume":"70","author":"TC Chou","year":"2010","unstructured":"Chou TC. Drug combination studies and their synergy quantification using the Chou-Talalay method. Cancer Res. 2010;70:440\u20136.","journal-title":"Cancer Res"},{"key":"1670_CR58","doi-asserted-by":"publisher","first-page":"280","DOI":"10.15252\/embr.201439949","volume":"16","author":"R Pagliarini","year":"2015","unstructured":"Pagliarini R, Shao W, Sellers WR. Oncogene addiction: pathways of therapeutic response, resistance, and road maps toward a cure. EMBO Rep. 2015;16:280\u201396.","journal-title":"EMBO Rep"},{"key":"1670_CR59","doi-asserted-by":"publisher","first-page":"417","DOI":"10.18632\/oncotarget.1708","volume":"5","author":"CA Vaughan","year":"2014","unstructured":"Vaughan CA, Deb SP, Deb S, Windle B. Preferred binding of gain-of-function mutant p53 to bidirectional promoters with coordinated binding of ETS1 and GABPA to multiple binding sites. Oncotarget. 2014;5:417\u201327.","journal-title":"Oncotarget"},{"key":"1670_CR60","doi-asserted-by":"publisher","first-page":"362","DOI":"10.1158\/2159-8290.CD-23-0402","volume":"14","author":"Z Wang","year":"2024","unstructured":"Wang Z, Burigotto M, Ghetti S, Vaillant F, Tan T, Capaldo BD, et al. Loss-of-Function but Not Gain-of-Function Properties of Mutant TP53 Are Critical for the Proliferation, Survival, and Metastasis of a Broad Range of Cancer Cells. Cancer Discov. 2024;14:362\u201379.","journal-title":"Cancer Discov"},{"key":"1670_CR61","doi-asserted-by":"publisher","DOI":"10.1038\/s41467-023-44239-2","volume":"15","author":"M Zhao","year":"2024","unstructured":"Zhao M, Wang T, Gleber-Netto FO, Chen Z, McGrail DJ, Gomez JA, et al. Mutant p53 gains oncogenic functions through a chromosomal instability-induced cytosolic DNA response. Nat Commun. 2024;15:180.","journal-title":"Nat Commun"},{"key":"1670_CR62","doi-asserted-by":"crossref","unstructured":"Jaber S, Eldawra E, Rakotopare J, Simeonova I, Lejour V, Gabriel M, et al. Oncogenic and teratogenic effects of Trp53(Y217C), an inflammation-prone mouse model of the human hotspot mutant TP53(Y220C). Elife. 2025;13:RP102434.","DOI":"10.7554\/eLife.102434.3"},{"key":"1670_CR63","doi-asserted-by":"publisher","first-page":"601","DOI":"10.1016\/j.molonc.2014.11.001","volume":"9","author":"A Maya-Mendoza","year":"2015","unstructured":"Maya-Mendoza A, Ostrakova J, Kosar M, Hall A, Duskova P, Mistrik M, et al. Myc and Ras oncogenes engage different energy metabolism programs and evoke distinct patterns of oxidative and DNA replication stress. Mol Oncol. 2015;9:601\u201316.","journal-title":"Mol Oncol"},{"key":"1670_CR64","doi-asserted-by":"publisher","first-page":"573","DOI":"10.1038\/ncb1571","volume":"9","author":"H Song","year":"2007","unstructured":"Song H, Hollstein M, Xu Y. p53 gain-of-function cancer mutants induce genetic instability by inactivating ATM. Nat Cell Biol. 2007;9:573\u201380.","journal-title":"Nat Cell Biol"},{"key":"1670_CR65","doi-asserted-by":"publisher","first-page":"577","DOI":"10.1158\/1541-7786.MCR-10-0534","volume":"9","author":"D Li","year":"2011","unstructured":"Li D, Marchenko ND, Schulz R, Fischer V, Velasco-Hernandez T, Talos F, et al. Functional inactivation of endogenous MDM2 and CHIP by HSP90 causes aberrant stabilization of mutant p53 in human cancer cells. Mol Cancer Res. 2011;9:577\u201388.","journal-title":"Mol Cancer Res"},{"key":"1670_CR66","doi-asserted-by":"publisher","first-page":"2685","DOI":"10.1158\/2767-9764.CRC-23-0637","volume":"4","author":"KK Chougoni","year":"2024","unstructured":"Chougoni KK, Neely V, Ding B, Oduah E, Lam VT, Hu B, et al. Oncogenic Mutant p53 Sensitizes Non-Small Cell Lung Cancer Cells to Proteasome Inhibition via Oxidative Stress-Dependent Induction of Mitochondrial Apoptosis. Cancer Res Commun. 2024;4:2685\u201398.","journal-title":"Cancer Res Commun"},{"key":"1670_CR67","doi-asserted-by":"publisher","first-page":"357","DOI":"10.1038\/nchembio.90","volume":"4","author":"A Montagnoli","year":"2008","unstructured":"Montagnoli A, Valsasina B, Croci V, Menichincheri M, Rainoldi S, Marchesi V, et al. A Cdc7 kinase inhibitor restricts initiation of DNA replication and has antitumor activity. Nat Chem Biol. 2008;4:357\u201365.","journal-title":"Nat Chem Biol"},{"key":"1670_CR68","doi-asserted-by":"publisher","first-page":"73925","DOI":"10.18632\/oncotarget.18034","volume":"8","author":"AJC Dohmen","year":"2017","unstructured":"Dohmen AJC, Qiao X, Duursma A, Wijdeven RH, Lieftink C, Hageman F, et al. Identification of a novel ATM inhibitor with cancer cell specific radiosensitization activity. Oncotarget. 2017;8:73925\u201337.","journal-title":"Oncotarget"},{"key":"1670_CR69","doi-asserted-by":"publisher","first-page":"491","DOI":"10.1016\/j.tranon.2017.04.002","volume":"10","author":"M Suzuki","year":"2017","unstructured":"Suzuki M, Yamamori T, Bo T, Sakai Y, Inanami O. MK-8776, a novel Chk1 inhibitor, exhibits an improved radiosensitizing effect compared to UCN-01 by exacerbating radiation-induced aberrant mitosis. Transl Oncol. 2017;10:491\u2013500.","journal-title":"Transl Oncol"},{"key":"1670_CR70","doi-asserted-by":"publisher","DOI":"10.1038\/ncomms1404","volume":"2","author":"B Dai","year":"2011","unstructured":"Dai B, Zhao XF, Mazan-Mamczarz K, Hagner P, Corl S, Bahassi el M, et al. Functional and molecular interactions between ERK and CHK2 in diffuse large B-cell lymphoma. Nat Commun. 2011;2:402.","journal-title":"Nat Commun"},{"key":"1670_CR71","doi-asserted-by":"publisher","first-page":"67","DOI":"10.1007\/978-1-4939-2522-3_5","volume":"1292","author":"B Mukherjee","year":"2015","unstructured":"Mukherjee B, Tomimatsu N, Burma S. Immunofluorescence-based methods to monitor DNA end resection. Methods Mol Biol (Clifton, NJ). 2015;1292:67\u201375.","journal-title":"Methods Mol Biol (Clifton, NJ)"},{"key":"1670_CR72","doi-asserted-by":"publisher","first-page":"4430","DOI":"10.1038\/sj.onc.1207553","volume":"23","author":"MJ Scian","year":"2004","unstructured":"Scian MJ, Stagliano KE, Deb D, Ellis MA, Carchman EH, Das A, et al. Tumor-derived p53 mutants induce oncogenesis by transactivating growth-promoting genes. Oncogene. 2004;23:4430\u201343.","journal-title":"Oncogene"},{"key":"1670_CR73","doi-asserted-by":"publisher","DOI":"10.21769\/BioProtoc.1374","volume":"5","author":"SH Kao","year":"2015","unstructured":"Kao SH, Wang WL, Chen CY, Chang YL, Wu YY, Wang YT, et al. Analysis of protein stability by the cycloheximide chase assay. Bio Protoc. 2015;5:e1374.","journal-title":"Bio Protoc"},{"key":"1670_CR74","doi-asserted-by":"publisher","first-page":"3823","DOI":"10.1021\/acs.jmedchem.7b01896","volume":"61","author":"KG Pike","year":"2018","unstructured":"Pike KG, Barlaam B, Cadogan E, Campbell A, Chen Y, Colclough N, et al. The Identification of Potent, Selective, and Orally Available Inhibitors of Ataxia Telangiectasia Mutated (ATM) Kinase: The Discovery of AZD0156 (8-{6-[3-(Dimethylamino)propoxy]pyridin-3-yl}-3-methyl-1-(tetrahydro-2 H-pyran-4-yl)-1,3-dihydro-2 H-imidazo[4,5- c]quinolin-2-one). J Med Chem. 2018;61:3823\u201341.","journal-title":"J Med Chem"}],"container-title":["Cell Death &amp; Differentiation"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.nature.com\/articles\/s41418-026-01670-4.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/s41418-026-01670-4","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/s41418-026-01670-4.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,8,3]],"date-time":"2026-08-03T14:03:57Z","timestamp":1785765837000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.nature.com\/articles\/s41418-026-01670-4"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,1,26]]},"references-count":74,"journal-issue":{"issue":"8","published-print":{"date-parts":[[2026,8]]}},"alternative-id":["1670"],"URL":"https:\/\/doi.org\/10.1038\/s41418-026-01670-4","relation":{"has-preprint":[{"id-type":"doi","id":"10.21203\/rs.3.rs-7303237\/v1","asserted-by":"object"}]},"ISSN":["1350-9047","1476-5403"],"issn-type":[{"value":"1350-9047","type":"print"},{"value":"1476-5403","type":"electronic"}],"subject":[],"published":{"date-parts":[[2026,1,26]]},"assertion":[{"value":"5 August 2025","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"10 December 2025","order":2,"name":"revised","label":"Revised","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"21 January 2026","order":3,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"26 January 2026","order":4,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"The authors declare no competing interests.","order":1,"name":"Ethics","label":"Competing interests","group":{"name":"EthicsHeading","label":"Ethics"}},{"value":"All animal experiments were approved (AM10234) and performed following the rules of the Institutional Animal Care and Use Committee (IACUC). Patient samples with informed consent for study participation in the manuscript were obtained from VCU Tissue and Data Acquisition and Analysis Core (TDAAC) approved by the Institutional Review Board.","order":2,"name":"Ethics","label":"Ethics approval","group":{"name":"EthicsHeading","label":"Ethics"}}]}}